Matribhumi Samachar English
Vancouver, British Columbia–(Newsfile Corp. – August 21, 2025) – BuildDirect.com Technologies Inc. (TSXV: BILD) (OTCQB: BDCTF) (“BuildDirect” or the “Company”), a leading omnichannel building material retailer, today announced that the Company will report its second quarter 2025 financial results before the market open on Thursday, August 28, 2025. Management will …
Read More »AITX’s Steve Reinharz Issues Op-Ed to Reuters Declaring “AI Isn’t the Enemy. Standing Still Is.”
Reinharz Responds to Fears of Job Displacement, Urges Business Leaders and Consumers to Embrace AI’s Acceleration Detroit, Michigan–(Newsfile Corp. – August 21, 2025) – Artificial Intelligence Technology Solutions, Inc. (OTCID: AITX) (the Company), today announced that its CEO/CTO and founder, Steve Reinharz, has issued an op-ed to Reuters responding to recent coverage …
Read More »InZinc Intersects 19.1 m grading 3.3% Zn, 0.7% Pb and 7.4 g/t Ag from 30 m downhole, including 8.5% Zn, 2.1% Pb and 21.3 g/t Ag over 2.0 m – Further Expanding Shallow Mineralization at Indy Sedex Project, Central BC
Vancouver, British Columbia–(Newsfile Corp. – August 21, 2025) – InZinc Mining Ltd. (TSXV: IZN) (“InZinc” or the “Company”) is pleased to report an additional four drill holes from 2025 exploration diamond drilling at its 100% owned Indy Sedex (zinc-lead-silver-barite) project, located 90 km southeast of Prince George in central British …
Read More »Legacy Gold Commences Drilling on the Baner Gold Mine Property in Central Idaho
Calgary, Alberta–(Newsfile Corp. – August 21, 2025) – Legacy Gold Mines Ltd. (TSXV: LEGY) (the “Company” or “Legacy Gold“) announces that drilling is underway on the Baner property (the “Baner Gold Mine Property“) to test the views of Legacy Gold’s geologists that the zones of gold mineralization at the Baner …
Read More »Data Watts Partners Inc. Announces Ron Loborec as CEO
Vancouver, British Columbia–(Newsfile Corp. – August 21, 2025) – Data Watts Partners Inc (CSE: DWTZ) further to the previous announcement of the acquisition of global consulting firm Agilitas Advisory, the Company now welcomes Ron Loborec as Chief Executive Officer, effective immediately. Mr. Loborec had been the Managing Partner of Agilitas …
Read More »Graphene Manufacturing Group Ltd. Announces Upsize of Bought Deal Public Offering for Gross Proceeds of C$6 Million
Brisbane, Queensland, Australia–(Newsfile Corp. – August 21, 2025) – Graphene Manufacturing Group Ltd. (TSXV: GMG) (OTCQX: GMGMF) (“GMG” or the “Company“) is pleased to announce that as a result of strong investor demand, the Company has increased the size of its previously announced “bought deal” public offering (the “Underwritten Offering“) …
Read More »Barnwell’s Largest Shareholder Demands Investigation Into $3 Million Texas Loss and Urges Action to Recover Millions for Investors
Vero Beach, Florida–(Newsfile Corp. – August 21, 2025) – The Sherwood Group, a long-term and significant shareholder with approximately 29.90% of the issued and outstanding shares of Barnwell Industries, Inc. (“Barnwell” or “BRN”), issued the following letter today to shareholders of Barnwell: Dear Fellow Shareholders of Barnwell Industries, Inc.: As …
Read More »NervGen Pharma’s NVG-291-R Demonstrates Significant Functional Recovery in Department of Defense-Sponsored Preclinical Models of Traumatic Hearing Loss and Peripheral Nerve Injury
Demonstrated significant hearing restoration in blast-induced sensorineural hearing loss models Promoted significant functional recovery and axonal regeneration in peripheral nerve injury models Reinforced NVG-291’s broad therapeutic potential with new data across three distinct injury models Vancouver, British Columbia–(Newsfile Corp. – August 21, 2025) – NervGen Pharma Corp. (TSXV: NGEN) (OTCQB: …
Read More »Medicus Pharma Ltd. Provides Update on Doxorubicin Containing Novel Microneedle Array (D-MNA) Clinical Development Program for the Treatment of Basal Cell Carcinoma (BCC) of the Skin and Reports Second Quarter 2025 Financial Highlights
US Food and Drug Administration (FDA) has accepted the company’s Type C meeting request and SKNJCT-003 Phase 2 study has randomized more than 75% of patients Philadelphia, Pennsylvania–(Newsfile Corp. – August 21, 2025) – Medicus Pharma Ltd. (NASDAQ: MDCX) (“Medicus” or the “Company”), a biotech/life sciences company focused on advancing …
Read More »Kuya Announces Second Tranche Closing of Non-Brokered Private Placement Pursuant to the Listed Issuer Financing Exemption
Toronto, Ontario–(Newsfile Corp. – August 21, 2025) – Kuya Silver Corporation (CSE: KUYA) (OTCQB: KUYAF) (FSE: 6MR1) (the “Company” or “Kuya Silver“) announces the second and final tranche closing of its non-brokered private placement previously announced July 24, 2025 and amended August 13, 2025 (the “Offering“). The Company issued 2,280,000 …
Read More »